GR3004747T3 - - Google Patents

Info

Publication number
GR3004747T3
GR3004747T3 GR920401069T GR920401069T GR3004747T3 GR 3004747 T3 GR3004747 T3 GR 3004747T3 GR 920401069 T GR920401069 T GR 920401069T GR 920401069 T GR920401069 T GR 920401069T GR 3004747 T3 GR3004747 T3 GR 3004747T3
Authority
GR
Greece
Application number
GR920401069T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620825A external-priority patent/GB8620825D0/en
Priority claimed from GB878702129A external-priority patent/GB8702129D0/en
Priority claimed from GB878703435A external-priority patent/GB8703435D0/en
Application filed filed Critical
Publication of GR3004747T3 publication Critical patent/GR3004747T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR920401069T 1986-08-28 1992-05-28 GR3004747T3 (US20020128544A1-20020912-P00008.png)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868620825A GB8620825D0 (en) 1986-08-28 1986-08-28 Organic compounds
GB878702129A GB8702129D0 (en) 1987-01-30 1987-01-30 Organic compounds
GB878703435A GB8703435D0 (en) 1987-02-13 1987-02-13 Organic compounds

Publications (1)

Publication Number Publication Date
GR3004747T3 true GR3004747T3 (US20020128544A1-20020912-P00008.png) 1993-04-28

Family

ID=27263135

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401069T GR3004747T3 (US20020128544A1-20020912-P00008.png) 1986-08-28 1992-05-28

Country Status (17)

Country Link
EP (1) EP0258191B1 (US20020128544A1-20020912-P00008.png)
JP (1) JPH0631236B2 (US20020128544A1-20020912-P00008.png)
KR (1) KR880002870A (US20020128544A1-20020912-P00008.png)
AU (1) AU600021B2 (US20020128544A1-20020912-P00008.png)
CA (1) CA1289954C (US20020128544A1-20020912-P00008.png)
DE (1) DE3779374D1 (US20020128544A1-20020912-P00008.png)
DK (1) DK169337B1 (US20020128544A1-20020912-P00008.png)
ES (1) ES2033922T3 (US20020128544A1-20020912-P00008.png)
FI (1) FI87356C (US20020128544A1-20020912-P00008.png)
GR (1) GR3004747T3 (US20020128544A1-20020912-P00008.png)
HU (1) HU199840B (US20020128544A1-20020912-P00008.png)
IE (1) IE60512B1 (US20020128544A1-20020912-P00008.png)
IL (1) IL83659A (US20020128544A1-20020912-P00008.png)
MY (1) MY101830A (US20020128544A1-20020912-P00008.png)
NZ (1) NZ221571A (US20020128544A1-20020912-P00008.png)
PH (1) PH24761A (US20020128544A1-20020912-P00008.png)
PT (1) PT85594B (US20020128544A1-20020912-P00008.png)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9020921D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds
DE4129603A1 (de) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
GB9210839D0 (en) * 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
CA2206804C (en) 1994-12-13 2002-03-19 Euro-Celtique, S.A. Trisubstituted thioxanthines
US6066641A (en) 1994-12-13 2000-05-23 Euro-Celtique S.A. Aryl thioxanthines
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
JP4450365B2 (ja) 2001-08-28 2010-04-14 シェーリング コーポレイション 多環式グアニンホスホジエステラーゼv阻害剤
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP3366698A1 (en) 2011-03-01 2018-08-29 Synergy Pharmaceuticals Inc. Guanylate cyclase c agonists
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
WO2014197720A2 (en) 2013-06-05 2014-12-11 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase c, method of making and using same
EP3492106B1 (en) 2013-08-09 2021-02-17 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1024968B (de) * 1956-03-31 1958-02-27 Asal Fabrik Biolog Und Pharmaz Verfahren zur Herstellung von 7-Ketonyl-8-amino-theophyllinen
AT212847B (de) * 1959-08-13 1961-01-10 Hans Dr Med Voigt Verfahren zur Herstellung des neuen Coffeino-(8)-(β-Phenyl-isopropyl)-amin
FR2157727A1 (en) * 1971-10-29 1973-06-08 Brun Lab Sa Le !,#dimethyl-8-aminopurines - with analgesicantitussive and other theophylline-like activities
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
DE3400951A1 (de) * 1984-01-13 1985-07-18 Robert Bosch Gmbh, 7000 Stuttgart Verfahren und vorrichtung zur drehzahlregelung bei einer brennkraftmaschine
HU197746B (en) * 1985-09-05 1989-05-29 Sandoz Ag Process for producing xantin derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI873704A0 (fi) 1987-08-26
HUT47111A (en) 1989-01-30
IE60512B1 (en) 1994-07-27
PT85594B (pt) 1990-05-31
FI87356C (fi) 1992-12-28
EP0258191B1 (en) 1992-05-27
HU199840B (en) 1990-03-28
FI87356B (fi) 1992-09-15
IE872296L (en) 1988-02-28
IL83659A0 (en) 1988-01-31
DK448787D0 (da) 1987-08-27
ES2033922T3 (es) 1993-04-01
DK448787A (da) 1988-02-29
DK169337B1 (da) 1994-10-10
EP0258191A1 (en) 1988-03-02
IL83659A (en) 1991-06-10
DE3779374D1 (en) 1992-07-02
JPH0631236B2 (ja) 1994-04-27
PT85594A (en) 1987-09-01
AU7744587A (en) 1988-03-03
JPS6363679A (ja) 1988-03-22
AU600021B2 (en) 1990-08-02
NZ221571A (en) 1990-11-27
PH24761A (en) 1990-10-01
KR880002870A (ko) 1988-05-12
FI873704A (fi) 1988-02-29
CA1289954C (en) 1991-10-01
MY101830A (en) 1992-01-31

Similar Documents

Publication Publication Date Title
FR2602816B1 (US20020128544A1-20020912-P00008.png)
IN169188B (US20020128544A1-20020912-P00008.png)
AU7131891A (US20020128544A1-20020912-P00008.png)
IN168374B (US20020128544A1-20020912-P00008.png)
IN165533B (US20020128544A1-20020912-P00008.png)
GR3004747T3 (US20020128544A1-20020912-P00008.png)
GR3005633T3 (US20020128544A1-20020912-P00008.png)
IN170532B (US20020128544A1-20020912-P00008.png)
IN168215B (US20020128544A1-20020912-P00008.png)
IN167686B (US20020128544A1-20020912-P00008.png)
AU7354491A (US20020128544A1-20020912-P00008.png)
IN168342B (US20020128544A1-20020912-P00008.png)
IN170426B (US20020128544A1-20020912-P00008.png)
AU6562586A (US20020128544A1-20020912-P00008.png)
KR880000228U (US20020128544A1-20020912-P00008.png)
AU7131791A (US20020128544A1-20020912-P00008.png)
AU5348186A (US20020128544A1-20020912-P00008.png)
AU5329886A (US20020128544A1-20020912-P00008.png)
AU5703286A (US20020128544A1-20020912-P00008.png)
AU5684886A (US20020128544A1-20020912-P00008.png)
AU4596985A (US20020128544A1-20020912-P00008.png)
AU5655786A (US20020128544A1-20020912-P00008.png)
AU5480786A (US20020128544A1-20020912-P00008.png)
AU4910985A (US20020128544A1-20020912-P00008.png)
AU4946385A (US20020128544A1-20020912-P00008.png)